Effects of transtympanic intermittent pressure therapy using a new tympanic membrane massage device for intractable Meniere’s disease and delayed endolymphatic hydrops: a prospective study.

Effects of transtympanic intermittent pressure therapy using a new tympanic membrane massage device for intractable Meniere’s disease and delayed endolymphatic hydrops: a prospective study.
复制标题

使用新型鼓膜按摩装置进行经鼓室间歇压力治疗对顽固性梅尼埃病和迟发性内淋巴积水的效果:一项前瞻性研究。

DOI:
10.1080/00016489.2021.1942979
复制
发表时间:
2022
期刊:
Acta Otolaryngol.
影响因子:
--
通讯作者:
Watanabe Y.
Watanabe Y.
中科院分区:
--
文献类型:
--
作者:
Shojaku H;Aoki M;Takakura H;Fujisaka M;Asai M;Tsubota M;Ito Y;Watanabe Y.

文献摘要

相似文献

背景回顾性研究表明,跨鼓膜按摩(TMM)装置治疗中耳压的效果与Meniett装置相似。目的前瞻性评价新型TMM装置EFET在梅尼埃病(MD)和迟发性内淋巴水肿(DEH)患者中的应用效果,并与梅尼埃特装置进行比较。材料与方法采用EFET装置治疗19例患者23耳,Meniett装置治疗15例患者17耳。所有顽固性MD和DEH患者均治疗4个月。对于Meniett装置,需要插入跨腔通气管,但对于EFET装置则不需要。结果经EFET和Meniett装置治疗的患者眩晕发生率明显改善。治疗后4个月眩晕结果的分布在两种装置治疗的患者之间没有差异。结论与意义EFET装置中耳压治疗效果良好,为难治性MD和DEH提供了与Meniett装置相同的微创治疗选择。
BackgroundThe retrospective study showed that the effect of the middle ear pressure treatment by the tramstympanic membrane massage (TMM) device was similar to that of the Meniett device.ObjectivesThe new TMM device named EFET device was prospectively evaluated in patients with Meniere’s disease (MD) and delayed endolymphatic hydrops (DEH) and we compared the effects to the Meniett device.Materials and methods23 ears of 19 patients were treated with an EFET device, and 17 ears of 15 patients were treated with the Meniett device. All patients suffering from intractable MD and DEH were treated for 4 months. The insertion of a transtympanic ventilation tube was necessary for the Meniett device, but not the EFET device.ResultsIn patients treated by the EFET and Meniett devices, the frequency of vertigo significantly improved after treatment. The distribution of vertigo outcomes at 4 months after treatment did not differ between patients treated with the both devices.Conclusions and significanceMiddle ear pressure treatment by the EFET device is effective and provides minimally invasive options for intractable MD and DEH like the Meniett device.